Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Researchers discover that inflammation and aging contribute to non-viral liver cancer development. Green tea's role in reversing some of the pathway dysregulation that may contribute to the cancer ...

During a live event, Martin Voss, MD, reviewed the trials of lenvatinib plus pembrolizumab, cabozantinib plus nivolumab, and ...

Researchers with City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.

Alibaba Group’s research arm, Damo Academy, has achieved a groundbreaking milestone in medical AI with its cancer detection ...

During a live event, Shannon N. Westin, MD, MPH, and participants discussed their experience treating patients with ...

The virtual pathology platform enables pathologists ... The patient was a 66-year-old with non-alcoholic liver cirrhosis and hepatocellular carcinoma, a procedure conducted by the hospital's ...

The Risk Estimation of Tumor REcurrence After Transplant score accurately predicted hepatocellular carcinoma recurrence after liver transplantation.

Ischemic hepatitis – intercorrelated pathology. Maedica (Bucur ... Symptoms & causes of cirrhosis. American Liver Foundation. Hepatocellular carcinoma. Rueda M, Lipsett PA. Hepatic failure. Principle ...